Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

# The origins of malaria artemisinin resistance defined by a genetic and transcriptomic background

## Abstract

The predisposition of parasites acquiring artemisinin resistance still remains unclear beyond the mutations in Pfk13 gene and modulation of the unfolded protein response pathway. To explore the chain of casualty underlying artemisinin resistance, we reanalyze 773 P. falciparum isolates from TRACI-study integrating TWAS, GWAS, and eQTL analyses. We find the majority of P. falciparum parasites are transcriptomically converged within each geographic site with two broader physiological profiles across the Greater Mekong Subregion (GMS). We report 8720 SNP-expression linkages in the eastern GMS parasites and 4537 in the western. The minimal overlap between them suggests differential gene regulatory networks facilitating parasite adaptations to their unique host environments. Finally, we identify two genetic and physiological backgrounds associating with artemisinin resistance in the GMS, together with a farnesyltransferase protein and a thioredoxin-like protein which may act as vital intermediators linking the Pfk13 C580Y mutation to the prolonged parasite clearance time.

## Introduction

Plasmodium falciparum, the causative agent of the most severe form of human malaria is once again threatening human health around the world1. After the largely successful world-wide elimination efforts that reduced malaria-related mortality and morbidity over the last decade, resistance of P. falciparum to the currently used artemisinin-based chemotherapeutics presents a new challenge for the future2,3. P. falciparum strains resistant to artemisinin were first reported in western Cambodia in 20094, and was subsequently detected in other parts of Southeast Asia5 including regions near India6. It is generally understood that an import of artemisinin resistance to Africa (presumably via India) will have a devastating effect, causing millions of deaths and other severe social and economic setbacks7,8. Hence, it will be crucial to understand all biological aspects of artemisinin resistance, particularly its emergence and spread9,10. This knowledge will not only help to manage the current situation but possibly also to guide future deployments of new malaria chemotherapies.

The current phenotype of artemisinin resistance is associated with nonsynonymous single nucleotide polymorphisms (SNPs) in the sequence encoding the Kelch13 (PfK13) propeller domain of P. falciparum11. The causative pfk13 SNPs were detected in P. falciparum isolates in western Cambodia as early as 2009 and in other regions of the Greater Mekong Subregion (GMS) in the following years12,13. Up to 26 nonsynonymous SNPs of the pfk13 gene, linked to artemisinin resistance, were identified in P. falciparum isolates from Southeast Asia between 2009 and 20145,9,14. Using haplotype analyses, Takala-Harison et al.15 demonstrated that at least 12 of the pfk13 SNPs emerged independently in several regions of Laos, Myanmar and Cambodia and spread locally. Only two of the identified mutations, C580Y and Y493H, exhibited a long distance transmission pattern from Cambodia to Vietnam. C580Y has only recently reached a state of fixation in many parts of the GMS, being transmitted in the context of two distinct long-range haplotypes, one of which originates in Cambodia and the other in Myanmar16. Hence, the currently spreading phenotype of artemisinin resistance appears to be a consequence of a selection process that maximizes survival and transmission of the most efficient genotype/genetic background of P. falciparum parasites.

Only limited information exists about the putative genetic and transcriptomic backgrounds supporting the pfk13 mutations in conferring artemisinin resistance. First, the malaria parasite cohort in the western Cambodian province, Pailin, the epicenter of artemisinin resistance, exhibits a highly unusual structure characterized by skewed allele frequency spectra and high haplotype homozygosity; indicating a strong founder effect17. Second, GWAS studies identified at least five SNPs that are strongly associated with artemisinin resistance and presumably contribute to the resistance-driven phenotype18. Third, an additional set of SNPs co-segregated with the pfk13 SNPs (particularly with C580Y) across the GMS between 2001 and 201419. Finally, artemisinin resistance is associated with a specific transcriptional profile that is characterized by induction of the unfolding protein response (UPR) and deceleration of the intraerythrocytic developmental cycle (IDC)20,21.

To explore this further, we carried out a large-scale bioinformatics analysis combining whole genome sequences and transcriptomes from 773 P. falciparum field isolates collected across seven countries in Southeast Asia between 2011 and 20135,18,20 during the Tracking Resistance to Artemisinin Collaboration (TRACI). Utilizing eQTL analysis, we captured two distinct physiological and genetic makeups that are different between the e- and w-GMS. Furthermore, using an eQTL analysis, we identified distinct set of genetic/physiological background for artemisinin-resistant parasites in e-GMS and w-GMS with key proteins, the farnesyltransferase protein of PF3D7_1242600 and the thioredoxin-like protein of PF3D7_0717900, which may mediate the Pfk13 C580Y effect on artemisinin-resistant parasites. Overall, we outline new genetic and transcriptional factors that contribute to the emergence and spread of artemisinin resistance in the GMS and beyond.

## Results

### Population transcriptomics of the GMS P. falciparum

Initially, we re-analyzed the TRACI P. falciparum transcriptome dataset of 773 isolates20 in order to dissect transcriptional changes that reflect physiological states of individual parasites within the patients. Principal component analysis (PCA) revealed that the major transcriptional differences among the field isolates are reflections of the parasite IDC progression (the 1st and 2nd PCs) and gametocytogenesis (the 1st and 3rd PCs, Supplementary Fig. 1a, b). Hence, we estimated the dominating IDC stage (hour post invasion, HPI) and the proportion of the sexual forms (gametocytes, GAM) in each parasite sample using a mathematical model based on maximum likelihood with the reference in vitro transcriptional profiles of the IDC22 and stage IV/V gametocytes (Methods). This allowed us to estimate the life cycle representation (HPI and GAM) of P. falciparum parasites in the peripheral blood samples at the individual TRACI field sites. We found that the isolates collected in Pailin, Shwe Kyin, and Ramu presented increased GAM proportions (median > 5%). Conversely, parasites from Attapeu, Preah Vihear, Rattanakiri, and Mae Sot exhibited decreased GAM proportions (median < 2%) (Fig. 1a). Also, the parasite cohorts from Attapeu, Ratanakiri and Binh Phuoc were skewed towards younger ring stages (median HPI ~6.6–7 h) while the parasites from Mae Sot and Ramu seemed older (median HPI ~7.8–8.5 h). Interestingly, the increased GAM proportion coincided with a high occurrence of artemisinin resistance in Pailin, while a decreased GAM proportion and advanced HPI coincided with the high level of artemisinin resistance in Mae Sot.

In the next step, we adjusted the transcriptome dataset for the HPI and GAM biases using a linear regression model by extracting residual expression values (Methods). This allowed us to construct a transcriptional dataset that reflects the actual adaptation of the individual parasites to its host environment. As expected the PCA of these adjusted transcriptomes showed much more dispersed GAM and HPI distribution (Supplementary Fig. 1c, d) and revealed additional components that are associated with the individual site cohorts (Supplementary Data 1). Inspecting the standard deviation of the corrected expression we observed that greatest transcriptional variability is generally exhibited by genes related to host-parasite interactions, such as host cell remodeling, cytoadhesion, antigenic variation, and host cell invasion; and also to metabolic and cellular processes, such as lipid metabolism, glycolysis, protein trafficking, and endoplasmic reticulum (ER) stress (Supplementary Fig. 2). Regarding the genes encoding surface antigens, we particularly detect most variable expression for the phist gene family, rifins, stevors, knob-associated histidine-rich protein (kahrp), mature-parasite-infected erythrocyte surface antigen (mesa), ring-infected erythrocyte surface antigen (resa), surfins, and genes encoding Maurer’s cleft components. This indicates the pivotal role of these genes in general adaptation of P. falciparum parasites to their host environment at the regional level.

To investigate transcriptome regionalization, we measured transcriptome differentiation within each geographic location/site for each individual parasite cohort. For this, we developed the Transcriptome Local Convergence index (Tcvs), which is derived as a normalized ratio of the transcriptome distance between local and global/distal sample sets using the transcriptome dataset adjusted for HPI and GAM (Methods). The Tcvs showed a marked regional conservation of transcriptomes with the majority (89%) of GMS P. falciparum isolates forming positive Tcvs peaks at individual sites (Fig. 1b, blue and Supplementary Data 2). The highest local convergence was observed in Preah Vihear (p-value = 1e–16, Mann–Whitney U test of Tcvs against the entire GMS), Shwe kyin (p-value = 5e–13, Mann–Whitney U test) and Binh Phuoc (p-value = 2e–4, Mann–Whitney U test). On the contrary, a smaller proportion of the GMS P. falciparum isolates (11%) exhibited local divergence from their counterparts (Fig. 1b, magenta). The most significant divergence was observed in Pailin where 32% of the isolates presented zero or negative Tcvs (p-value = 2.8e–10, χ2 test against the expected frequency of 11%); and Pursat where Tcvs scores are the most close to zero. A Gene Set Enrichment Analysis (GSEA) revealed that the geographical transcriptome convergence is driven predominantly by genes involved in ribosome biogenesis and structure, ubiquitin-dependent protein catabolic process, translation, RNA processing, DNA damage repair, glycolysis, redox homeostasis, and phospholipid metabolism. Conversely, transcriptome divergence seems to be determined by genes involved in cytoadhesion, ER-associated protein catabolic process, GPI anchor biosynthesis, DNA replication, and exported proteins such as the PHIST gene family. Significant transcriptome diversion in Pailin and Pursat was also found to be associated with genes in involved in rosette formation, cellular redox homeostasis, ER stress, fatty acid biosynthesis, mitosis, and merozoite invasion (Supplementary Data 3).

There was a high level of genetic relatedness of the individual cohorts in all sites including those with the transcriptionally diverse parasites such as Pailin and Pursat and to some degree Ranong and Ramu (Supplementary Fig. 3a). This suggests that while some of the observed transcriptional differences are linked to the local genetically driven adaptations, others (especially those with the greatest variations) are related to other processes, such as stress response which is discussed in the section of eQTL mapping and association studies of artemisinin resistance. However, the founder-like (sub)populations defined genetically in some of the study sites17 do not correlate directly with the transcriptional differences (Supplementary Fig. 3b-f). This is consistent with our initial hypothesis suggesting that (some) transcriptional variations might have preceded the genetic diversion within the individual sites. Some epidemiological aspects such as drug resistance could drive the local transcriptional diversion. This is demonstrated by the increased diversion (Tcvs < 0) of Pailin parasites that carry the piperaqine resistance marker, amplification of plasmepsin II–III23, that reached 50% prevalence in this (sub)regions in 2011–2013 (Supplementary Fig. 3g)3.

### Diverged physiological backgrounds in the GMS

Previous genetic studies have suggested a strong separation of P. falciparum populations between the western and eastern parts of Southeast Asia (w-GMS and e-GMS)18. The w-GMS includes Bangladesh, Myanmar, western and southern Thailand, while the e-GMS includes the core GMS including Cambodia, Laos and their border regions with Thailand and Southern Vietnam. Multidimensional scaling analysis of the genotypes of 773 P. falciparum isolates confirmed this geographical separation (Supplementary Fig. 4 and Methods). Moreover, phylogenetic tree construction based on pairwise transcriptome distances also revealed a general separation between the w-GMS and e-GMS P. falciparum parasites, albeit to a lesser degree (Fig. 2a). The w-GMS sub-branch included the majority of P. falciparum isolates from Bangladesh and Myanmar (72%) but also a small proportion (12%) of e-GMS isolates. The e-GMS branch contained 85% of the parasites from Cambodia, 84% from Thailand, 99% from Vietnam, and 100% from Laos. Peculiar population stratification was formed by the parasites from the western border regions of Thailand (Mae Sot), which were genetically close to w-GMS populations but transcriptionally intermixed with e-GMS populations almost equally.

To parse the physiological differentiation, we designed an index of gene expression Frequency (geF) denoting the proportion of isolates with increased mRNA levels compared to the average level across the GMS based on the HPI and GAM adjusted data. K-means clustering (k = 6) of geF on 5061 genes mainly presented two patterns (Fig. 2b). First, isolates from the e-GMS showed increased geF for genes involved in early ribosome biogenesis, hemoglobin digestion, nuclear import/export, and mitochondrial antioxidant system (Grp1), as well as purine/pyrimidine metabolism and organization of the kinetochore (Grp2). On the other hand, the w-GMS isolates showed significantly higher geF values for genes involved in DNA mismatch repair and DNA replication complex formation, nucleosome assembly, and proteasomal degradation (Grp6). Similar geF values were observed in e-GMS and w-GMS isolates for genes in Grp3, Grp4, and Grp5 (Supplementary Data 4). These results suggest that the genetic differences in geographically delineated P. falciparum populations may be converted into transcription-driven physiological states and are characterized by the probability of transcriptional upregulation/downregulation of individual genes potentially reflecting the adaptation of malaria parasites to varying epidemiological aspects. These processes may reflect such global regional groupings (e.g., w- and e-GMS) but also potentially more localized adaptation processes within each site that could be masked in this analysis by the global sample grouping. Data provided in this manuscript could facilitate future studies within the individual site-specific cohorts to uncover the transcriptomic-driven adaptation in a greater detail.

### eQTL mapping

Next, performed eQTL analyses to understand the genetic determinants of physiological variations in the two P. falciparum GMS populations. Essentially, we mapped the expression of 5061 genes onto 28,594 high-confidence SNPs with minor allele frequency (MAF) > 0.01. The SNP dataset included 17,589 (62%) SNPs from protein-coding regions and 11,005 (38%) SNPs from introns or intergenic regions. The expression data was normalized to minimize non-genetic component effects through the removal of top-selected PCs using linear regression analogously to other reported eQTL analyses in other eukaryotic systems24,25,26,27,28. Finally, the eQTL mapping was carried out in two independent panels for w-GMS and e-GMS populations with 229 and 544 genotyped parasites represented in the each group (Methods). Overall, we uncovered 8,720 SNP-expression linkages in e-GMS (Supplementary Data 5) and 4537 linkages in w-GMS (Supplementary Data 6) at p-value < 1e–05 (FDR < 0.25 by expression permutation). For subsequent functional analysis, we selected the highest confidence 5575 linkages (Supplementary Data 7) that showed no contradictory associations between e-GMS and w-GMS (Fig. 3a and Methods). These 5575 linkages represented associations between 3972 polymorphisms (eQTLs) and 2350 transcripts. We found 47% of the eQTLs appear to be physically linked, being enriched in up to 58 chromosomal clusters (Fig. 3a and Supplementary Data 8). The strongest clustering was observed on chromosome 10 (134,0673 bp to 1,511,622 bp) with 171 eQTL occurrences and an over-representation of intergenic eQTLs (p-value = 3e−07, binomial test against overall SNPs). However, only 3% of eQTLs associated with more than three transcripts. The top eQTL had 41 putative transcript targets and it was located at 730, 268 on chromosome 7 within an eQTL cluster (Pf3D7_07_v3: 706,086–772,669 bp) representing a nonsynonymous SNP producing a L721F substitution for gene PF3D7_0716700. In the future, it will be interesting to study these eQTLs hotspots for their potential functions as key transcriptional regulatory mechanisms.

Crucially, there appears to be major differences in the distal eQTLs obtained from e-GMS as compared to w-GMS. This is demonstrated by a mutually exclusive pattern of the distal eQTL regulations represented by the logarithm odds ratios (LOD) differentiation between e-GMS and w-GMS (Fig. 3c, blue). Essentially, no distal linkages manifesting on one side of the GMS (west or east) exhibited a similar association on the other. This is in contrast to the local linkages for which concordant associations can be observed on both sides of the GMS (Fig. 3c, yellow). Note, the LOD scores differentiation of the distal linkages is not a result of sample size or PCs normalization as randomized sub-samplings resulted in significantly high correlations (Fig. 3c, inset and Methods). Importantly, the mutually exclusive pattern of the e- and w-GMS segregation was observed for both cis- and trans-acting distal eQTLs, separately (supplementary Fig. 6). This pattern is also preserved across multiple MAF thresholds and eQTL significance cutoffs. Overall, this dramatic difference in the distal eQTL profiles further strengthens the above-mentioned concept of the division of P. falciparum populations between w-GMS and e-GMS showing even a stronger separation than those demarcated by the genomic and transcriptomic profiles alone.

### Association studies of artemisinin resistance

Taking the regional differences into consideration, we performed a genome- and transcriptome-wide association study (G/TWAS) of artemisinin resistance with the 229 w-GMS and 544 e-GMS isolates separately (Fig. 4). The clinical phenotype of artemisinin resistance was expressed as the parasite clearance time5,18,31,32. GWAS in the e-GMS confirmed a strong association with the pfk13 C580Y and three previously identified SNPs18 producing a N96D substitution in gene PF3D7_1343100 of unknown function, N821K in pfrad5 (DNA repair protein PF3D7_1343400)32 and a synonymous substitution of 103L in pfap2-o4 (ApiAP2 transcription factor PF3D7_1350900), but also a previously unidentified intergenic SNP between gene PF3D7_1412400 and actin II (PF3D7_1412500) (Fig. 4a and Supplementary Table 2). In the w-GMS, GWAS identified two polymorphisms including a synonymous SNP of 501 T in gene PF3D7_0827600 and a nonsynonymous SNP, H511R, in pfripr (PF3D7_0323400) encoding for a Rh5-interacting protein involved in host cell invasion (Supplementary Table 3). In contrast, the TWAS identified as many as 365 genes whose transcriptional levels were associated with artemisinin resistance in either or both the e-GMS (Supplementary Data 10) and w-GMS (Supplementary Data 11) with equal statistical significance cutoff of p-value < 0.01 (Spearman’s rho test) and FDR < 0.25 (Benjamini & Hochberg correction) (Fig. 4b). Crucially, the majority of the artemisinin resistance-linked transcripts differed between e-GMS and w-GMS with only 19 genes upregulated and four genes downregulated commonly between the two GMS divisions at FDR < 0.25 (Fig. 4b, black circled). These included pfmdr1, pfap2-tel, pfap2-sp, pfprp2, and pfmsp7-like. However, in spite of the major differences there was a general agreement in the functional assignments of differentially expressed genes involved in artemisinin resistance, which include factors of ribosome biogenesis, RNA metabolism and exported proteins (Supplementary Fig. 7). Similarly, autophagy, DNA replication, cell adhesion, cell redox homeostasis and ribosomal structure exhibited down-regulation in both divisions. Interestingly, there was also common upregulation for several global cellular processes; albeit different sub-components detected in either of the division. The main example is the UPR, a putative effector of artemisinin resistance20, with factors related to ER stress upregulated in e-GMS and ubiquitin-related processes and proteasome-mediated degradation upregulated in w-GMS. Finally, we also observed distinct regional differences in artemisinin resistance-associated upregulation including genes involved in models for ubiquitin chain amputation in e-GMS and intracellular protein transport in w-GMS (Supplementary Data 12). Overall, the TWAS showed a stronger correlation of transcription levels to artemisinin resistance in e-GMS with 275 genes compared to 113 genes in the w-GMS (p-value < 0.01 and FDR < 0.25).

To better understand the causality of artemisinin resistance, we investigated further the results from GWAS, TWAS and eQTLs. We found that two out of the five SNP markers identified by GWAS, the pfk13 C580Y and a synonymous SNP in pfap2-o4, were linked with transcription in e-GMS (Fig. 4c). In particular, pfk13 C580Y was positively correlated with the expression of farnesyltransferase (PF3D7_1242600) at p-value = 9e−06 (FDR = 0.006, permutation test) and negatively correlated with that of thioredoxin-like protein (PF3D7_0717900) at p-value = 2e−06 (FDR = 0.03, permutation test). Transcription of genes coding for farnesyltransferase and thioredoxin-like protein were also related to artemisinin resistance at p-value = 1e−05 (FDR = 0.006, permutation test) and p-value = 2e−04 (FDR = 0.03, permutation test), respectively (Fig. 4c). On the other hand, the putative interaction between pfap2-o4 and 5′–3′ exonuclease (PF3D7_0204600) (eQTL p-value = 2e−06 and FDR = 0.02, permutation test) appears independent of artemisinin resistance (TWAS p-value = 0.4, Spearman’s rho test) (Fig. 4d). The other three SNP markers associated with artemisinin resistance in e-GMS showed no eQTLs-like effects on any P. falciparum gene (Fig. 4e). However, our eQTL analysis detected a set of 363 SNPs, which could be linked with artemisinin resistance via regulating expression of 141 genes (Fig. 4f and Supplementary Data 13). Two examples of such eQTL-expression pairs are a local linkage wiring PF3D7_0404800 C9Y (Pf3D7_04_v3-266145) to the 6-cysteine gene (PF3D7_0404900, p-value = 2e−07) and a distal linkage wiring PF3D7_1024400 P428A (Pf3D7_10_v3-1023588) to the MDR1 gene (PF3D7_0523000, p-value = 4e−09). It is feasible to suggest that at least some of the 363 eQTLs contribute to the genetic background of artemisinin-esistant parasites. These polymorphisms could operate together with another 132 genes whose expression is associated with resistance but are independent of genetic control (Fig. 4g). Similarly, w-GMS data defined another genetic background of 108 eQTLs linking to artemisinin resistance via controlling transcription variation of 47 genes (Supplementary Data 14).

## Discussion

Earlier studies on in vivo samples of P. falciparum have revealed that major variation of transcriptional levels occurs in genes encoding factors involved in host-parasite interactions33,34. This concept was subsequently expanded into the view of distinct physiological states of malaria parasites in vivo defined by transcriptional regulation of a broader spectrum of genes with multiple biological functions35. Specifically, it was proposed that the parasite cellular physiology could be (at least in part) controlled by fine-tuned transcriptional profiles of genes regulating active growth via glycolysis and/or alternative carbon source metabolism as well as other environmental stress responses. Distinct global transcriptional variations can also be associated with disease-related phenotypes such as malaria infection during pregnancy36,37 and severe malaria with cerebral complications38,39. While pregnancy-associated malaria seems mainly associated with upregulation of genes encoding specific surface antigens (such as var and phist genes), the severe infections involve parasites with more complex transcriptional changes in processes such as energy metabolism, biosynthesis, protein synthesis and folding, and cytoadhesion. Global transcriptional profiles seem to also govern distinct physiologies selected by transmission40. In particular, genes associated with fast growth and development such as transcription, translation, DNA replication, and energy metabolism are upregulated in parasites with high transmission while factors of sexual reproduction, motility and lipid metabolism are induced in parasites in low transmission areas. Following our initial work20, here we show that distinct transcriptional/physiological states also occur amongst parasite populations with similar transmission levels and in patients with similar disease outcome (uncomplicated malaria in semi-immune individuals)5. These results suggest that transcriptional regulation underlies parasite adaptation on even a finer scale reflecting local geographical regions potentially driven by subtle variations in malaria epidemiological aspects. These reflect the evolution of genetically distinct P. falciparum sub-populations in Western Cambodia that are thought to occur due to several factors, such as inbreeding, low transmission rate, geographical and/or reproductive isolation, high drug pressure and oxidative stress (due to hemoglobinopathies)31.

This eQTL analysis of P. falciparum in vivo isolates mirrors the previous in vitro study of the progeny of a genetic cross between two P. falciparum strains. Both studies showed that the distal eQTLs are more common compared to the local eQTLs, and that many of these are clustered within genetic hotspots41. Similarly, a large portion of these in vitro linkages involved a broad spectrum of protein functions beyond transcriptional regulation, with sequence polymorphisms altering their biological properties (e.g., missense mutations) and/or expression (e.g., CNV)42,43. These profiles of P. falciparum eQTLs from both in vitro samples41 and in vivo samples (shown here) are similar to those observed in other unicellular organisms such as yeast24. In Saccharomyces cerevisiae, the majority of transcriptional variations can be linked to cis- or trans-acting distal genetic loci involving factors of signal transduction, cytoskeleton, and protein metabolism as well as enzymes and proteins of other basic cellular function appeared to regulate transcriptional diversity44,45. Here, we demonstrated that malaria parasites also possess such a regulatory network that allows them to acquire differential physiological states and thus adapt to their unique host environment. The distal (cis- and trans-acting) linkages appear to facilitate these long-term adaptations, likely reflecting unique epidemiological factors that differentiate parasite populations in large geographical regions such as e-GMS and w-GMS. This regional adaptation likely results from a long-term accumulation of subtle variations of distal eQTLs involving a broad spectrum of cellular functions ranging from growth and development to basic metabolism and host cell remodeling40. However, besides the genetically driven transcriptional changes, some of the detected transcriptional variations are undoubtedly also controlled epigenetically. This may involve factors of heterochromatin, such as P. falciparum heterochromatin protein (PfHP1) that was shown to associate predominantly with transcriptionally variable genes46; and the histone 4 acetylation at lysine 8 (H4K8ac) marker that was shown to regulate several factors of growth and host-parasite interaction in the reverse relationship47. In summary, notwithstanding the epigenetic effect, it is feasible to speculate that the distal eQTLs may represent key components of putative genetic background(s) that maintain specific transcriptional and physiological states, which could predispose the malaria parasites to major phenotypic shifts, such as drug resistance18.

Here, we explored this possibility by investigating artemisinin resistance as the major phenotypic transformation that is currently ongoing in the GMS5,16,48. Previously, we have shown that artemisinin resistance (mediated by PfK13 mutations) is more likely to occur in parasites with upregulated UPR pathways and decelerated IDC progression20,21. Now, we extend this model with several additional observations. Firstly, while in most sites of the GMS the parasite cohorts exhibit a strong physiological conversion, in Pailin and Pursat, the epicenters of artemisinin resistance4, the parasites are transcriptionally highly diverse (Fig. 1b). Such physiological flexibility can boost the likelihood of initial emergence and local spread of drug resistance by selecting additional supporting genetic changes. This is consistent with the observations that PfK13 mutations were initially rising in multiple events along the GMS15 but were ultimately overrun by a dominating haplotype with C580Y SNP spreading from Western Cambodia3,16. In the future, it will be crucial to decipher the full catalog of these putative supportive variations that renders the Pailin genotypes most successful. This information will be particularly crucial to understand and monitor the spread of drug resistance beyond the GMS49 and ultimately to Africa where currently PfK13 mutations occur in very low frequencies and do not confer any resistant phenotype50. Second, we observed a major division in parasite physiology between the east and western part of the GMS that is mediated by essentially mutually exclusive sets of distal eQTLs (Fig. 3c) as well as differential frequencies of transcriptional upregulations (Fig. 2b). This further supports the initial genetic studies18, and indicates a potential of additional genetic/physiological backgrounds that promote the spread of artemisinin resistance based on distinct genotypes. These genotypes could include distinct PfK13 mutations such as F446I first reported in Myanmar51. Third, while the PfK13 polymorphisms remain currently the most predictive markers52, we identified a new set of genetic and transcriptional variations that significantly associate with artemisinin resistance (Fig. 4c–g). In particular, we identified up to 405 genes whose expression is related to artemisinin resistance and from these 167 genes are linked with 496 distal eQTLs. These factors may also contribute to artemisinin resistance either as direct mechanistic components or alleviating elements as a part of a complex genetic trait. It is feasible to suggest that these genetic/transcriptional factors are holding the key in a potential spread of PfK13-dependent resistance phenotypes (given the possibility of spontaneous rise of PfK13 SNPs) or constitute a new PfK13-independent mechanism(s), some of which were reported in vivo53,54 and in vitro55.

## Methods

### Ethics statement

In this study, we analyzed published data of P. falciparum parasites including SNPs and transcriptome which were derived from field samples. All studies providing the data were approved by the appropriate local ethics committees or the Oxford Tropical Research Ethics Committee. All samples were collected from patients’ blood with informed consent from the patient or a parent or guardian.

### Filtration of single nucleotide polymorphisms and samples

The SNP dataset was provided by the Sanger Institute. SNPs were discovered against the P. falciparum 3D7 reference sequence V3 using 2375 samples from Africa and Asia. It is accessible via [ftp://ngs.sanger.ac.uk/production/pf3k/release_5/5.1/]. We extracted out 2,174,070 high quality polymorphisms for 1069 isolate samples which had their transcriptome measured. To reduce artifacts and effects of complex infections, we only selected SNPs with two alleles and the minimal allele frequency (MAF) > 0.01 across the GMS. We also discarded samples with more than half of all SNPs not established or presenting other than biallelic polymorphisms. Finally, we considered 28,594 high quality SNPs and 773 isolate samples in this study.

### P. falciparum transcriptome

The raw data of 773 P. falciparum transcriptomes in this study was identical to that in Mok’s study20 which are accessible through NCBI’s Gene Expression Omnibus (GEO) Series accession number GSE59099. The data was processed by loess-normalization within arrays followed by quantile-normalization between samples/arrays using the Limma56 package of R. This method identified a transcriptome of 5061 genes which were represented in >67% of all samples/arrays with probes showing median foreground intensity > 1.5-fold median background intensity for either channel. Missing values (<2% of total detected log2 ratios) were refilled by nearest neighbor averaging algorithm in the R package of impute. The processed expression data of 773 isolates are provided in Supplementary Data 15.

### Estimation of parasites HPI and GAM proportion

For each individual parasite population/sample, we estimated its most proximate age (hours post invasion, HPI) during the asexual intraerythrocytic developmental cycle (IDC) and the proportion of gametocytes using a mixture model based on a maximum likelihood method. The method is adjusted from the model described in Lemieux’s work57. In this study, the mixture model is constructed by some proportion of asexual parasites and another proportion of gametocytes that is presented in formula as:

$$y_{\mathrm{g}} = \left( {1 - \alpha } \right)^\ast x_{\mathrm{g}}\left( {{\mathrm{hr}}} \right) + \alpha ^\ast z_{\mathrm{g}}\left( d \right) + \varepsilon _{\mathrm{g}}$$
(1)

where yg is the gene expression values of a field site sample; α is the proportion of gametocytes to the total parasite count (sum of gametocytes and asexual parasites); xg(hr) is the gene expression values of the reference asexual sample at the HPI of hour hr; zg is the gene expression values of the reference gametocyte sample at the day of d and the εg is the associated error term. The error term εg is estimated using differences between all the isolate samples and lab strains. The reference transcriptomes of asexual stages were generated by Bernardo et al.22 in the P. falciparum Dd2 strain with 24 time points obtained during the IDC with 2 h intervals. To estimate HPI at a high resolution, the reference IDC transcriptomes were interpolated into 240 time points with 0.2 h intervals using smooth splines in this study. The reference gametocyte transcriptome were generated in 3D7 strain parasites after PfHP1 depletion58 and collected at the 1st to 12th day during the parasites gametocyte development. The data was uploaded to Gene Expression Omnibus and the accession number is GSE121505. The R script is provided in Supplementary Software 1.

The principal component analysis (PCA) on 32 reference transcriptomes (24 from asexual parasites and eight from gametocyte parasites) reveals that a separation of IDC and GAM transcriptomes is clearly interpretable by the first three PCs (Supplementary Fig. 1f, panel on the top right). Based on the top three PCs, we observed strong differences among field site isolates in their HPI age of asexual parasites and proportions of gametocytes by projecting TRACI samples onto the space of the first three PCs (Supplementary Fig. 1e, f).

In order to remove the expression variation caused by parasite age of an individual sample and its proportion of GAM parasites, we corrected expression values for each gene by extracting expression residuals from the fitted linear model where HPI and GAM proportion were used as covariates. To fit the linear model, we utilized the logit transformation of GAM proportion and also added a covariate of squared HPI due to the polynomial-like relationship between the expression profiles and parasite age. PCA to the adjusted data showed a successful reduction of impact of GAM and HPI on the transcriptome (Supplementary Fig. 1c, d). The adjusted expression data is provided in Supplementary Data 16.

### Transcriptome Local Conservation index (Tcvs)

Tcvs score was designed to measure the distance of an individual transcriptome to the local cohort against the entire cohort of whole GMS. The Tcvs is defined as:

$$Tcvs_i = 1 - \frac{{{\mathrm{ED}}_{{\mathrm{Ti.within}}}}}{{{\mathrm{ED}}_{{\mathrm{Ti.broad}}}}}$$
(2)

where EDTi.within represents the average Euclidean distance of transcriptomes between the ith sample to randomly selected 1000 samples from its local field site; EDTi.broad represents the average Euclidean distance of transcriptomes between the ith sample to randomly selected 1000 samples from the entire GMS pool. The transcriptome pool of GMS parasites was generated by 5000 times sub-sampling with each field site cohorts presented at the same frequency. The Euclidean distance of two transcriptomes was calculated based on the standardized expression data after HPI and GAM proportion adjustment.

To investigate functional gene sets associated to the local convergence/divergence of parasites transcriptomes across the GMS, we developed a gene expression fixation index (geFST) to measure the expression differentiation at each field site for individual genes. The geFST is defined as:

$$geFST_{gi} = 1 - \frac{{{\mathrm{ED}}_{{\mathrm{gi.within}}}}}{{{\mathrm{ED}}_{{\mathrm{gi.broad}}}}}$$
(3)

The Euclidean distance was calculated for the ith gene, gi, between two randomly selected isolates. Here, EDgi.within represents the average Euclidean distance of 1000 random isolate pairs sampled within a local field site; and EDgi.broad represents the average Euclidean distance between 1000 random isolate pairs sampled from the given field site and entire GMS pool. Then, geFST values were normalized into z-scores for each field site and the averaged z-scores were calculated for 5061 individual genes across field sites and used in the following GSEA study. The most conserved/diverged pathways throughout all field sites were determined in GSEA at p-value < 0.05 and FDR < 0.25 based on isolates presenting positive Tcvs scores. For the field sites of Pursat and Pailin, which displayed the highest transcriptome diversion (see main text), geFST was individually calculated using the entire set of local samples, 89 isolates at Pursat and 76 at Pailin. It resulted in 106 and 147 significantly diverged gene expressions at z-score < −2 for Pursat and Pailin, respectively. The pathways enriched of diverged genes at Pursat/Pailin were obtained at p-value < 0.05 with hypergeometric test. Full list of enriched pathways are listed in Supplementary Data 3.

To compare parasites transcriptome relatedness to the genome, we calculated the Genome Local Conservation index (Gcvs) analogous to the Tcvs index. The Gcvs is defined as:

$$Gcvs_i = 1 - \frac{{D_{{\mathrm{Gi.within}}}}}{{D_{{\mathrm{Gi.broad}}}}}$$
(4)

where DGi.within represents the average genetic distance between the ith sample to randomly selected 1000 samples from its local field site. DGi.broad represents the average genetic distance between the ith sample to randomly selected 1000 samples from the entire GMS pool. The pairwise genetic distance of samples was estimated based on the genetic similarity matrix which was generated by FaST-LMM using unlinked SNPs. We subtracted the similarity scores from 1 and used that to indicate the genetic distance between samples.

### Transcriptome population structure

The transcriptome population structure was reconstructed using a neighbor-joining tree for the 773 isolate samples across eleven field sites of the GMS. The distance matrix used for clustering was calculated as Euclidean distance of pairwise transcriptomes based on the corrected expression data (HPI and GAM proportion adjusted), which was also centered to the sample mean with the standard deviation scaled to 1.

### Population stratification

Samples within the e/w-GMS still present subpopulation stratifications. The possible population structure was estimated using four multidimensional scaling (MDS) vectors, which was obtained from the 16,614 unlinked SNPs. The 16,614 unlinked SNPs were defined out of the 28,594 SNPs using Plink v2.8 LD-based variant pruner with –indep-pairwise option, parameter settings of window size=100 kb, and the square correlation cutoff R2 > 0.3 in step size of 10.

### eQTL mapping

The eQTL mapping was performed for e-GMS and w-GMS independently using the same processing pipeline. For each region, the corrected expression data of 5061 genes were considered as 5061 traits and mapped to the 28,594 high quality SNPs. The test of SNP-expression association was implemented using FaST-LMM v2.0759 with the genetic similarity matrix estimated based on unlinked SNPs.

### Gene expression correction and PCA adjustment

To achieve more detectable eQTLs we processed expression data with the following procedures aiming to minimize the impact of non-genetic components on the expression variations, which is generally applied to eQTL analyses in other systems also24,25,26,27,28. First, utilizing the four MDS vectors estimated on the above, the expression data was corrected for the possible population structure by extracting the residuals from a linear regression. Second, a PCA was performed to the 544 e-GMS (229 w-GMS) transcriptomes to generate top 50 principal components (PCs) to capture major expression differences among samples which may be due to physiological, environmental or systematic experimental variations24,25,26,27,28. Association analysis of those PCs confirmed their correlations to the estimated parasite age (HPI), gametocyte proportion, and numbers of known clinical factors like parasite counts, sample origin, patient temperature and other host-related factors (Supplementary Data 1). Third, we picked top 20 PCs for expression correction based on the inflection point of the percent variation curve of the 50 PCs (Supplementary Fig. 8). In addition, the eQTL numbers on chromosome 13 were also optimized at 20 PCs correction with no significant increment by removing more. Fourth, we performed QTL analysis for the 20 PCs by mapping each to the 28,594 SNPs using FaST-LMM. According to their relationships to genotype, we subtracted 5 of the 20 PCs from the next correction steps for e-GMS. Finally, expression values were corrected for each gene by determining the residuals using linear regression with the selected PCs as covariates. For the w-GMS dataset, we applied the same procedure with considering only top 10 PCs because of the smaller sample size of 229 isolates.

After expression adjustment, PCA was repeated to the adjusted data to investigate the efficiency of removing non-genetic component effects. The results revealed a successful reduction of environmental effects from the adjusted expression values (Supplementary Data 1). All the potential environmental factors, the known and estimated, are listed in Supplementary Data 17.

### eQTLs quality control

Since eQTL mapping generates multiple testing results and the confounding effects vary across genes and may hence not be fully captured by the top 20 PCA components, we applied expression permutation to control the FDR for the individual populations (w-GMS and e-GMS parasites) independently. For each gene, we shuffled the sample IDs within sites to maintain the transcriptome structure of sub-region isolates. Given the heavy computation of permutations required by eQTLs analysis, the permutation was performed in a small scale for 2400 genes which was randomly selected from the potential targets of eQTLs (p-value < 1e−05); and the mapping was restricted to unlinked SNPs derived from Plink LD pruning (-indep-pairwise 1000 20 0.2 -maf 0.01) which resulted in 9229 SNPs for e-GMS and 8422 SNPs for w-GMS. Next, according to the permutation results, we constructed the null distribution of p-values for eQTL mappings to SNPs with 0.01 < MAF < 0.05 separately from those to SNPs with MAF > 0.05, aiming to provide more justified FDR values to SNP-expression associations with different MAF levels. The results showed that the cutoff of p-value < 1e−5 called e-GMS eQTLs at FDR < 0.06 for SNPs with MAF > 0.05, and FDR < 0.2 for SNPs with 0.01 < MAF < 0.05; and called w-GMS eQTLs correspondingly at FDR < 0.1 and FDR < 0.25 for each MAF category. The estimated FDR values are provided together with p-values for each eQTL in Supplementary Data 5 and 6.

With the cutoff of p-value < 1e−05, the eQTL mapping initially detected 9,541 SNP-expression linkages for e-GMS and 11,293 linkages for w-GMS with the input data of 5061 genes expression and 28,594 high quality SNPs. For each detected linkage of SNP-expression pair, we further performed 100 times permutation tests with shuffling the sample IDs within sites per time. A linkage would be discarded if any permutation results passed the threshold of p-value < 1e−5. This removed 820 linkages from e-GMS and 6756 linkages from w-GMS. Finally, the eQTL mapping resulted in 8720 SNP-expression linkages in e-GMS and 4537 linkages in w-GMS.

To achieve a high-confidence dataset for holistic eQTL analysis in P. falciparum parasites, we pruned the union results from e-GMS and w-GMS by removing linkages showing contradictory association effects between them. In practice, we ignored linkages with positive log2 odds ratio (LOD) in one sub-region but negative LOD in the other; if a SNP with very low minimum allele counts (≤5) was found with low LOD (between −1 and 1), it was also removed from further analysis. Finally, the high-confidence dataset containing a total of 5575 SNP-expression linkages were composed of 3452 e-GMS linkages and 2170 w-GMS linkages. The 5575 linkages uncovered 3972 eQTL SNPs associating to transcriptional variations of 2350 genes. For the 3972 identified eQTL SNPs, 1072 (27%) underlay the eQTL regions observed by Gonzales’s in vitro study41.

### eQTL clusters

There were 2837 out of 3972 eQTLs falling beyond the linkage disequilibrium according to the Plink LD-based variant pruning described above. The eQTL clusters were defined based on the 2837 unlinked eQTLs. A 50 kb sliding window was used to scan regions along each chromosome. Windows with over-representation of eQTLs were defined at p-value < 0.05 by χ2 test against the expected number for each chromosome. Consecutive enriched windows were merged into one if the adjusted p-value < 0.05 was obtained for the merged window. Finally, it resulted in 58 eQTL clusters covering 47% (or 1867) of the 3972 eQTLs.

### Sub-sampling of eQTL mapping

Sub-samplings were performed to the e-GMS populations three times. Each round, 229 (the same number of w-GMS isolates) samples were randomly selected from the e-GMS populations and the eQTL mapping pipeline were repeated using all the same parameters previously applied to the w-GMS data analysis. The detail steps included re-estimating the population structures of sub-sampled isolates using multidimensional scaling factors, re-calculating PCA components of the transcriptome populations and the number of top components used for expression normalization. The SNP-expression association was tested for all the high-confidence 5575 SNP-expression linkages.

### Genome-wide association study (GWAS)

GWAS was performed using a linear mixed model in FaST-LMM v2.07 together with the correction for population structure. With the threshold of MAF > 0.01, we tested 24,652 SNPs for their associations to parasite clearance time in the e-GMS, and 22,216 SNPs in the w-GMS. The parasite clearance time denotes the parasite clearance half-lives estimated using a parasite clearance estimator32,60. The number of SNP markers detected at a gradual significant level are summarized in Supplementary Fig. 9a. A minor overlapping was observed between w-GMS and e-GMS. The full results of GWAS are listed in Supplementary Table 2 and 3.

### Transcriptome-wide association study (TWAS)

TWAS was carried out for the e-GMS and w-GMS populations individually by applying linear regressions between mRNA levels and parasite clearance time for each gene. The mRNA levels were corrected for HPI and GAM proportions before TWAS. In addition, due to the significant correlation between parasite clearance time and parasite origins, we removed the geographic effects from both of the variations of parasite clearance half-life and gene expression using the same method of residuals as described above. Spearman’s rho was used to test for association between expression and clearance time without samples, which showed outlier expression (z-score > 3, z-scores are differences between each value and the mean divided by standard deviation). The FDR was estimated using Benjamini & Hochberg correction on p-value. The number of gene markers detected at a gradual significant level are summarized in Supplementary Fig. 9b. Given the different sample size in e-GMS and w-GMS, we conducted 100 times sub-sampling to the e-GMS data by randomly selecting 229 samples each time. The Spearman’s rho estimated at 75% confidence interval from sub-sampling did not show much difference from the original ones. This reveals the strong correlation observed in TWAS of e-GMS than w-GMS was not due to the bigger sample size. The full results of TWAS are listed in Supplementary Data 10 and 11.

### Code availability

The R script of mixture model used for estimating parasites HPI and GAM is available in Supplementary Software 1. All the tools and softwares applied in this study are described within the methods.

## Data availability

All data supporting the findings of this study are available within the article and its Supplementary Information files, or from the corresponding author upon request. The reference gametocyte transcriptome has been uploaded to Gene Expression Omnibus under accession number GSE121505. The SNP dataset was provided by the Sanger Institute and is accessible via [ftp://ngs.sanger.ac.uk/production/pf3k/release_5/5.1/]. The raw data of P. falciparum transcriptomes is accessible through Gene Expression Omnibus (GEO) Series accession number GSE59099.

## References

1. 1.

World Health Organization. World Malaria Report 2014 (WHO, Geneva, 2014).

2. 2.

World Health Organization. Eliminating Malaria: Learning From the Past, Looking Ahead [http://www.pathorg/publications/files/MCP_rbm_pi_rpt_8pdf] (WHO, Geneva, 2011).

3. 3.

Amato, R. Modest effect of interferon alfa on metastatic renal-cell carcinoma. Lancet 353, 6–7 (1999).

4. 4.

Dondorp, A. M. et al. Artemisinin resistance in Plasmodium falciparum malaria. N. Engl. J. Med. 361, 455–467 (2009).

5. 5.

Ashley, E. A. et al. Spread of artemisinin resistance in Plasmodium falciparum malaria. N. Engl. J. Med. 371, 411–423 (2014).

6. 6.

Tun, K. M. et al. Spread of artemisinin-resistant Plasmodium falciparum in Myanmar: a cross-sectional survey of the K13 molecular marker. Lancet Infect. Dis. 15, 415–421 (2015).

7. 7.

Dondorp, A. M. et al. Artemisinin resicurrent status and scenarios for containment. Nat. Rev. Microbiol. 8, 272–280 (2010).

8. 8.

Lubell, Y. et al. Artemisinin resistance-modelling the potential human and economic costs. Malar. J. 13, 452 (2014).

9. 9.

Fairhurst, R. M. Understanding artemisinin-resistant malaria: what a difference a year makes. Curr. Opin. Infect. Dis. 28, 417–425 (2015).

10. 10.

Sibley, C. H. Understanding artemisinin resistance. Science 347, 373–374 (2015).

11. 11.

Straimer, J. et al. K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates. Science 347, 428–431 (2015).

12. 12.

Ariey, F. et al. A molecular marker of artemisinin-resistant Plasmodium falciparum malaria. Nature 505, 50–55 (2014).

13. 13.

Witkowski, B. et al. Novel phenotypic assays for the detection of artemisinin-resistant Plasmodium falciparum malaria in Cambodia: in-vitro and ex-vivo drug-response studies. Lancet Infect. Dis. 13, 1043–1049 (2013).

14. 14.

Menard, D. & Ariey, F. Towards real-time monitoring of artemisinin resistance. Lancet Infect. Dis. 15, 367–368 (2015).

15. 15.

Takala-Harrison, S. et al. Independent emergence of artemisinin resistance mutations among Plasmodium falciparum in Southeast Asia. J. Infect. Dis. 211, 670–679 (2014).

16. 16.

Imwong, M. et al. The spread of artemisinin-resistant Plasmodium falciparum in the Greater Mekong subregion: a molecular epidemiology observational study. Lancet Infect. Dis. 17, 491–497 (2017).

17. 17.

Miotto, O. et al. Multiple populations of artemisinin-resistant Plasmodium falciparum in Cambodia. Nat. Genet 45, 648–655 (2013).

18. 18.

Miotto, O. et al. Genetic architecture of artemisinin-resistant Plasmodium falciparum. Nat. Genet 47, 226–234 (2015).

19. 19.

Cerqueira, G. C. et al. Longitudinal genomic surveillance of Plasmodium falciparum malaria parasites reveals complex genomic architecture of emerging artemisinin resistance. Genome Biol. 18, 78 (2017).

20. 20.

Mok, S. et al. Population transcriptomics of human malaria parasites reveals the mechanism of artemisinin resistance. Science 347, 431–435 (2015).

21. 21.

Mok, S. et al. Artemisinin resistance in Plasmodium falciparum is associated with an altered temporal pattern of transcription. BMC Genom. 12, 391 (2011).

22. 22.

Foth, B. J., Zhang, N., Chaal, B. K., Sze, S. K., Preiser, P. R., Bozdech, Z. Quantitative time-course profiling of parasite and host cell proteins in the human malaria parasite Plasmodium falciparum. Mol. Cell Proteomics 10, M110.006411 (2011).

23. 23.

Bopp, S. et al. Plasmepsin II-III copy number accounts for bimodal piperaquine resistance among Cambodian Plasmodium falciparum. Nat. Commun. 9, 1769 (2018).

24. 24.

Albert, F. W. & Kruglyak, L. The role of regulatory variation in complex traits and disease. Nat. Rev. Genet 16, 197–212 (2015).

25. 25.

Fehrmann, R. S. et al. Trans-eQTLs reveal that independent genetic variants associated with a complex phenotype converge on intermediate genes, with a major role for the HLA. PLoS Genet. 7, e1002197 (2011).

26. 26.

Innocenti, F. et al. Identification, replication, and functional fine-mapping of expression quantitative trait loci in primary human liver tissue. PLoS Genet. 7, e1002078 (2011).

27. 27.

van Nas, A. et al. Expression quantitative trait loci: replication, tissue- and sex-specificity in mice. Genetics 185, 1059–1068 (2010).

28. 28.

Westra, H. J. et al. Systematic identification of trans eQTLs as putative drivers of known disease associations. Nat. Genet. 45, 1238–1243 (2013).

29. 29.

Ay, F. et al. Three-dimensional modeling of the P. falciparum genome during the erythrocytic cycle reveals a strong connection between genome architecture and gene expression. Genome Res. 24, 974–988 (2014).

30. 30.

Bunnik, E. M. et al. Changes in genome organization of parasite-specific gene families during the Plasmodium transmission stages. Nat. Commun. 9, 1910 (2018).

31. 31.

Amaratunga, C. et al. Artemisinin-resistant Plasmodium falciparum in Pursat province, western Cambodia: a parasite clearance rate study. Lancet Infect. Dis. 12, 851–858 (2012).

32. 32.

Takala-Harrison, S. et al. Genetic loci associated with delayed clearance of Plasmodium falciparum following artemisinin treatment in Southeast Asia. Proc. Natl Acad. Sci. USA 110, 240–245 (2013).

33. 33.

Daily, J. P. et al. In vivo transcriptional profiling of Plasmodium falciparum. Malar. J. 3, 30 (2004).

34. 34.

Daily, J. P. et al. In vivo transcriptome of Plasmodium falciparum reveals overexpression of transcripts that encode surface proteins. J. Infect. Dis. 191, 1196–1203 (2005).

35. 35.

Daily, J. P. et al. Distinct physiological states of Plasmodium falciparum in malaria-infected patients. Nature 450, 1091–1095 (2007).

36. 36.

Francis, S. E. et al. Six genes are preferentially transcribed by the circulating and sequestered forms of Plasmodium falciparum parasites that infect pregnant women. Infect. Immun. 75, 4838–4850 (2007).

37. 37.

Tuikue Ndam, N. et al. Plasmodium falciparum transcriptome analysis reveals pregnancy malaria associated gene expression. PLoS ONE 3, e1855 (2008).

38. 38.

Miller, L. H., Ackerman, H. C., Su, X. Z. & Wellems, T. E. Malaria biology and disease pathogenesis: insights for new treatments. Nat. Med. 19, 156–167 (2013).

39. 39.

Tonkin-Hill, G. Q. et al. The Plasmodium falciparum transcriptome in severe malaria reveals altered expression of genes involved in important processes including surface antigen-encoding var genes. PLoS Biol. 16, e2004328 (2018).

40. 40.

Rono, M. K. et al. Adaptation of Plasmodium falciparum to its transmission environment. Nat. Ecol. Evol. 2, 377–387 (2018).

41. 41.

Gonzales, J. M. et al. Regulatory hotspots in the malaria parasite genome dictate transcriptional variation. PLoS Biol. 6, e238 (2008).

42. 42.

Reilly Ayala, H. B., Wacker, M. A., Siwo, G. & Ferdig, M. T. Quantitative trait loci mapping reveals candidate pathways regulating cell cycle duration in Plasmodium falciparum. BMC Genom. 11, 577 (2010).

43. 43.

Samarakoon, U., Gonzales, J. M., Patel, J. J., Tan, A., Checkley, L. & Ferdig, M. T. The landscape of inherited and de novo copy number variants in a Plasmodium falciparum genetic cross. BMC Genom. 12, 457 (2011).

44. 44.

Matsui, T. & Ehrenreich, I. M. Gene-environment interactions in stress response contribute additively to a genotype-environment interaction. PLoS Genet. 12, e1006158 (2016).

45. 45.

Yvert, G. et al. Trans-acting regulatory variation in Saccharomyces cerevisiae and the role of transcription factors. Nat. Genet. 35, 57–64 (2003).

46. 46.

Fraschka, S. A. et al. Comparative heterochromatin profiling reveals conserved and unique epigenome signatures linked to adaptation and development of malaria parasites. Cell Host Microbe 23, 407–420 (2018). e408.

47. 47.

Gupta, A. P., Zhu, L., Tripathi, J., Kucharski, M., Patra, A. & Bozdech, Z. Histone 4 lysine 8 acetylation regulates proliferation and host-pathogen interaction in Plasmodium falciparum. Epigenetics Chromatin 10, 40 (2017).

48. 48.

Dondorp, A. M. et al. The threat of artemisinin-resistant malaria. N. Engl. J. Med. 365, 1073–1075 (2011).

49. 49.

Mohon, A. N. et al. Mutations in Plasmodium falciparum K13 propeller gene from Bangladesh (2009-2013). Malar. J. 13, 431 (2014).

50. 50.

MalariaGEN Plasmodium falciparum Community Project. Genomic epidemiology of artemisinin resistant malaria. Elife 5, e08714 (2016).

51. 51.

Huang, F. et al. A single mutation in K13 predominates in Southern China and is associated with delayed clearance of Plasmodium falciparum following artemisinin treatment. J. Infect. Dis. 212, 1629–1635 (2015).

52. 52.

Menard, D. et al. A worldwide map of Plasmodium falciparum K13-propeller polymorphisms. N. Engl. J. Med. 374, 2453–2464 (2016).

53. 53.

Mukherjee, A. et al. Artemisinin resistance without pfkelch13 mutations in Plasmodium falciparum isolates from Cambodia. Malar. J. 16, 195 (2017).

54. 54.

Muwanguzi, J., Henriques, G., Sawa, P., Bousema, T., Sutherland, C. J. & Beshir, K. B. Lack of K13 mutations in Plasmodium falciparum persisting after artemisinin combination therapy treatment of Kenyan children. Malar. J. 15, 36 (2016).

55. 55.

Rocamora, F. et al. Oxidative stress and protein damage responses mediate artemisinin resistance in malaria parasites. PLoS Pathog. 14, e1006930 (2018).

56. 56.

Ritchie, M. E. et al. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).

57. 57.

Lemieux, J. E. et al. Statistical estimation of cell-cycle progression and lineage commitment in Plasmodium falciparum reveals a homogeneous pattern of transcription in ex vivo culture. Proc. Natl Acad. Sci. USA 106, 7559–7564 (2009).

58. 58.

Brancucci, N. M. B. et al. Heterochromatin protein 1 secures survival and transmission of malaria parasites. Cell Host Microbe 16, 165–176 (2014).

59. 59.

Lippert, C., Listgarten, J., Liu, Y., Kadie, C. M., Davidson, R. I. & Heckerman, D. FaST linear mixed models for genome-wide association studies. Nat. Methods 8, 833–835 (2011).

60. 60.

Flegg, J. A., Guerin, P. J., White, N. J. & Stepniewska, K. Standardizing the measurement of parasite clearance in falciparum malaria: the parasite clearance estimator. Malar. J. 10, 339 (2011).

## Acknowledgements

We thank the healthcare workers involved in sample collection across all sites.

## Author information

Authors

### Contributions

L.Z. and Z.B. performed all the analysis of this study and drafted the manuscript; J.T. contributed to the manuscript preparation; F.M.R. contributed to GWAS implementation; O.M. prepared the genotype data of this study; T.S.V. shared gametocytes transcriptome data. S.M. prepared the isolates transcriptome data. Z.B., O.M., R.v.d.P., D.P.K., F.N., N.P.J.D., N.J.W. and A.M.D. contributed to study design. Tracking Resistance to Artemisinin Collaboration I authors carried out field and laboratory work to obtain P. falciparum samples. The manuscript was reviewed by all the authors.

### Corresponding author

Correspondence to Zbynek Bozdech.

## Ethics declarations

### Competing interests

The authors declare no competing interests.

Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

#A full list of consortium members appears at the end of the paper.

## Rights and permissions

Reprints and Permissions

Zhu, L., Tripathi, J., Rocamora, F.M. et al. The origins of malaria artemisinin resistance defined by a genetic and transcriptomic background. Nat Commun 9, 5158 (2018). https://doi.org/10.1038/s41467-018-07588-x

• Accepted:

• Published:

• ### A comprehensive RNA handling and transcriptomics guide for high-throughput processing of Plasmodium blood-stage samples

• Michal Kucharski
• Jaishree Tripathi
• Zbynek Bozdech

Malaria Journal (2020)